Using AAV vectors expressing the β(2)-adrenoceptor or associated Gα proteins to modulate skeletal muscle mass and muscle fibre size

Anabolic β(2)-adrenoceptor (β(2)-AR) agonists have been proposed as therapeutics for treating muscle wasting but concerns regarding possible off-target effects have hampered their use. We investigated whether β(2)-AR-mediated signalling could be modulated in skeletal muscle via gene delivery to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagg, Adam, Colgan, Timothy D., Thomson, Rachel E., Qian, Hongwei, Lynch, Gordon S., Gregorevic, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789796/
https://www.ncbi.nlm.nih.gov/pubmed/26972746
http://dx.doi.org/10.1038/srep23042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789796/
https://www.ncbi.nlm.nih.gov/pubmed/26972746
http://dx.doi.org/10.1038/srep23042

Ejemplares similares